sub:provenance {
  sub:assertion dcterms:description "[Similarly, there were no increased risks associated with the XRCC2 GA/AA genotype (OR, 0.98; 95% CI, 0.76-1.26 for breast cancer and OR, 0.93; 95% CI, 0.69-1.25 for ovarian cancer) or the XRCC3 CT/TT genotype (OR, 0.92; 95% CI, 0.77-1.10 for breast cancer and OR, 0.87; 95% CI, 0.71-1.08 for ovarian cancer).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ;
    
wi:evidence dgn-void:source_evidence_literature ;
    
sio:SIO_000772 miriam-pubmed:15734952 ;
    
prov:wasDerivedFrom dgn-void:BEFREE ;
    
prov:wasGeneratedBy eco:ECO_0000203 . 
  
dgn-void:BEFREE pav:importedOn "2017-02-19"^^
xsd:date . 
  
dgn-void:source_evidence_literature a eco:ECO_0000212 ;
    
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ;
    
rdfs:label "DisGeNET evidence - LITERATURE"@en . 
}